Our Research Publications
Updated August 2024
Pagination
- Previous page
- Page 24
- Next page
Title | Authors | Year Sort ascending | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
The potential role of a turbidimetric heart-type fatty acid-binding protein assay to aid in the interpretation of persistently elevated, non-changing, cardiac troponin I concentrations | Kavsak PA, Ainsworth C, Arnold DM, Scott T, Clark L, Ivica J, Mackett K, Whitlock R, Worster A | 2018 | Clin Biochem | View The potential role of a turbidimetric heart-type fatty acid-binding protein assay to aid in the interpretation of persistently elevated, non-changing, cardiac troponin I concentrations | Researchers | Basic research |
Synthesis of Highly Biocompatible and Temperature-Responsive Physical Gels for Cryopreservation and 3D Cell Culture | Nagao M, Sengupta J, Diaz-Dussan D, Adam M, Wu M, Acker J, Ben R, Ishihara K, Zeng H, Miura Y, Narain R | 2018 | ACS Appl Bio Mater | View Synthesis of Highly Biocompatible and Temperature-Responsive Physical Gels for Cryopreservation and 3D Cell Culture | Researchers | Basic research |
A multicentred study to validate a consensus bleeding assessment tool developed by the biomedical excellence for safer transfusion collaborative for use in patients with haematological malignancy | Dyer C, Alquist CR, Cole-Sinclair M, Curnow E, Dunbar NM, Estcourt LJ, Kaufman R, Kutner JM, McCullough J, McQuilten Z, Potiphar L, Rioux-Masse B, Slichter S, Tinmouth A, Webert K, Yokoyama AP, Stanworth SJ | 2018 | Vox Sang | View A multicentred study to validate a consensus bleeding assessment tool developed by the biomedical excellence for safer transfusion collaborative for use in patients with haematological malignancy | Health care providers | Clinical research |
Questioning some recommendations in the umbilical cord blood guideline | Elmoazzen H, Petraszko T | 2018 | J Obstet Gynaecol Can | View Questioning some recommendations in the umbilical cord blood guideline | Health care providers | New or improved product or process |
ResearchUnit: A model for change: predicting the impact of system-wide improvements | Blake J | 2018 | Blood.ca website | View ResearchUnit: A model for change: predicting the impact of system-wide improvements | Other | New or improved product or process |
Screening of red blood cells for extracellular vesicle content as a product quality indicator | Acker JP, Almizraq RJ, Millar D, Maurer-Spurej E | 2018 | Transfusion | View Screening of red blood cells for extracellular vesicle content as a product quality indicator | Researchers | New or improved product or process |
Anti-M (French) | Clarke G, Cote J, Lane D | 2018 | Blood.ca website | View Anti-M (French) | Researchers | Basic research |
Cyclic thrombocytopenia with statistically significant neutrophil oscillations | Langlois GP, Arnold DM, Potts J, Leber B, Dale DC, Mackey MC | 2018 | Clin Case Rep | View Cyclic thrombocytopenia with statistically significant neutrophil oscillations | Health care providers | Clinical research |
Low platelet count as risk factor for infections in patients with primary immune thrombocytopenia: a retrospective evaluation | Qu M, Liu Q, Zhao H-G, Peng J, Ni H, Hou M, Jansen AJG | 2018 | Ann Hematol | View Low platelet count as risk factor for infections in patients with primary immune thrombocytopenia: a retrospective evaluation | Health care providers | Clinical research |
Changes in plasma unit distributions to hospitals over a 10-year period | Seheult JN, Shaz B, Bravo M, Croxon H, Devine D, Doncaster C, Field S, Flanagan P, Germain M, Gregoire Y, Kamel H, Karafin M, Kelting N, Lewis M, O'Brien C, Murphy MF, Rossmann S, Sayers M, Shinar E, Takanashi M, Titlestad K, Yazer MH | 2018 | Transfusion | View Changes in plasma unit distributions to hospitals over a 10-year period | Blood operators | Clinical research |
ResearchUnit: Patient blood group impacts susceptibility to IVIg-associated hemolysis | Branch D | 2018 | Blood.ca website | View ResearchUnit: Patient blood group impacts susceptibility to IVIg-associated hemolysis | Researchers | Basic research |
A Deep Learning Method to Automatically Identify Reports of Scientifically Rigorous Clinical Research from the Biomedical Literature: Comparative Analytic Study | Del Fiol G MM, Iorio A, Cotoi C, Haynes RB | 2018 | J Med Internet Res | View A Deep Learning Method to Automatically Identify Reports of Scientifically Rigorous Clinical Research from the Biomedical Literature: Comparative Analytic Study | Researchers | Clinical research |
Circular of information for the use of human blood components: Platelets | Jenkins C | 2018 | Blood.ca website | View Circular of information for the use of human blood components: Platelets | Health care providers | Benchmarking and standard setting |
Aphérèse thérapeutique | Pavenski K | 2018 | Guide de la pratique transfusionnelle | View Aphérèse thérapeutique | Health care providers | Benchmarking and standard setting |
Systematic reviews of guidelines and studies for single versus multiple unit transfusion strategies | Shih AW, Liu A, Elsharawi R, Crowther MA, Cook RJ, Heddle NM | 2018 | Transfusion | View Systematic reviews of guidelines and studies for single versus multiple unit transfusion strategies | Researchers | Clinical research |
Plerixafor effectively mobilizes CD56bright NK cells in blood, providing an allograft predicted to protect against GVHD | Wong PPC, Kariminia A, Jones D, Eaves CJ, Foley R, Ivison S, Couban S, Schultz KR | 2018 | Blood | View Plerixafor effectively mobilizes CD56bright NK cells in blood, providing an allograft predicted to protect against GVHD | Health care providers | Clinical research |
Does my complex patient have DIC? | Shih A | 2018 | CanadiEM website | View Does my complex patient have DIC? | Health care providers | Other |
IgA deficiency | Goldman M | 2018 | Blood.ca website | View IgA deficiency | Health care providers | Benchmarking and standard setting |
The efficacy and safety of topical tranexamic acid: A systematic review and meta-analysis | Montroy J, Hutton B, Moodley P, Fergusson NA, Cheng W, Tinmouth A, Lavallee LT, Fergusson DA, Breau RH | 2018 | Transfus Med Rev | View The efficacy and safety of topical tranexamic acid: A systematic review and meta-analysis | Researchers | Clinical research |
Psychometric properties of the Patient Reported Outcomes, Burdens and Experiences (PROBE) questionnaire | Chai-Adisaksopha C, Skinner MW, Curtis R, Frick N, Nichol MB, Noone D, O'Mahony B, Page D, Stonebraker J, Thabane L, Crowther M, Iorio A | 2018 | BMJ Open | View Psychometric properties of the Patient Reported Outcomes, Burdens and Experiences (PROBE) questionnaire | Researchers | Clinical research |
Antiplatelet antibody-induced thrombocytopenia does not correlate with megakaryocyte abnormalities in murine immune thrombocytopenia | Guo L, Kapur R, Aslam R, Hunt K, Hou Y, Zufferey A, Speck ER, Rondina MT, Lazarus AH, Ni H, Semple JW | 2018 | Scand J Immunol | View Antiplatelet antibody-induced thrombocytopenia does not correlate with megakaryocyte abnormalities in murine immune thrombocytopenia | Researchers | Basic research |
How do we diagnose immune thrombocytopenia in 2018? | Kelton JG VJ, Arnold DM | 2018 | Hematology Am Soc Hematol Educ Program | View How do we diagnose immune thrombocytopenia in 2018? | Health care providers | Clinical research |
Past, present and future of haemophilia gene therapy: From vectors and transgenes to known and unknown outcomes | Pierce GF, Iorio A | 2018 | Haemophilia | View Past, present and future of haemophilia gene therapy: From vectors and transgenes to known and unknown outcomes | Health care providers | New or improved product or process |
Concurrence of symmetrical peripheral gangrene and venous limb gangrene following polytrauma: a case report | Tan JH, Mohamad Y, Tan CLH, Kassim M, Warkentin TE | 2018 | J Med Case Rep | View Concurrence of symmetrical peripheral gangrene and venous limb gangrene following polytrauma: a case report | Health care providers | Clinical research |
Exploring donor and product factors and their impact on red cell post-transfusion outcomes | Ning S, Heddle NM, Acker JP | 2018 | Transfus Med Rev | View Exploring donor and product factors and their impact on red cell post-transfusion outcomes | Health care providers | Clinical research |
Modeling the optimal ethnic composition of an adult stem cell registry | Blake JT, McTaggart K, Killeen D | 2018 | Eur J Oper Res | View Modeling the optimal ethnic composition of an adult stem cell registry | Blood operators | New or improved product or process |
Transfusion requirements in cardiac surgery III (TRICS III): study design of a randomized controlled trial | Shehata N, Whitlock R, Fergusson DA, Thorpe KE, MacAdams C, Grocott HP, Rubens F, Fremes S, Lellouche F, Bagshaw S, Royse A, Rosseel PM, Hare G, Medicis E, Hudson C, Belley-Cote E, Bainbridge D, Kent B, Shaw A, Byrne K, Syed S, Royse CF, McGuiness S, Hall J, Mazer CD | 2018 | J Cardiothorac Vasc Anesth | View Transfusion requirements in cardiac surgery III (TRICS III): study design of a randomized controlled trial | Researchers | Clinical research |
Utilization of frozen plasma, cryoprecipitate, and recombinant factor VIIa for children with hemostatic impairments: An audit of transfusion appropriateness | Lieberman L, Lin Y, Cserti-Gazdewich C, Yi QL, Pendergrast J, Lau W, Callum J | 2018 | Pediatr Blood Cancer | View Utilization of frozen plasma, cryoprecipitate, and recombinant factor VIIa for children with hemostatic impairments: An audit of transfusion appropriateness | Health care providers | Clinical research |
Antimicrobial peptides: an effective approach to prevent bacterial biofilm formation in platelet concentrates | Alabdullatif M, Atreya CD, Ramirez-Arcos S | 2018 | Transfusion | View Antimicrobial peptides: an effective approach to prevent bacterial biofilm formation in platelet concentrates | Researchers | New or improved product or process |
La maladie hémolytique du foetus et du nouveau-né et thrombopénie immune périnatale | Clarke G, Hannon J | 2018 | Guide de la pratique transfusionnelle | View La maladie hémolytique du foetus et du nouveau-né et thrombopénie immune périnatale | Health care providers | Other |
ResearchUnit: How does anti-D prevent hemolytic disease of the fetus and newborn? Lessons from a mouse model | Lazarus A | 2018 | Blood.ca website | View ResearchUnit: How does anti-D prevent hemolytic disease of the fetus and newborn? Lessons from a mouse model | Other | Other |
Pharmacokinetics and the transition to extended half-life factor concentrates: communication from the SSC of the ISTH | Ragni MV, Croteau SE, Morfini M, Cnossen MH, Iorio A | 2018 | J Thromb Haemost | View Pharmacokinetics and the transition to extended half-life factor concentrates: communication from the SSC of the ISTH | Health care providers | Basic research |
Heparin-induced thrombocytopenia-associated thrombosis: from arterial to venous to venous limb gangrene | Warkentin TE | 2018 | J Thromb Haemost | View Heparin-induced thrombocytopenia-associated thrombosis: from arterial to venous to venous limb gangrene | Health care providers | Benchmarking and standard setting |
Concentré de recherche: Rôle du groupe sanguin dans le déclenchement d'une hémolyse après l'administration d'immunoglobulines | Branch D | 2018 | Blood.ca website | View Concentré de recherche: Rôle du groupe sanguin dans le déclenchement d'une hémolyse après l'administration d'immunoglobulines | Researchers | Basic research |
Pathogen inactivation strategies to improve blood safety: Let's not throw pathogen-reduced platelets out with their bath water | Devine DV | 2018 | JAMA Oncol | View Pathogen inactivation strategies to improve blood safety: Let's not throw pathogen-reduced platelets out with their bath water | Researchers | New or improved product or process |
Circular of information for the use of human blood components: Plasma components | Jenkins C | 2018 | Blood.ca website | View Circular of information for the use of human blood components: Plasma components | Health care providers | Benchmarking and standard setting |
Systematic review of rituximab for autoimmune diseases: a potential alternative to intravenous immune globulin | MacIsaac J, Siddiqui R, Jamula E, Li N, Baker S, Webert KE, Evanovitch D, Heddle NM, Arnold DM | 2018 | Transfusion | View Systematic review of rituximab for autoimmune diseases: a potential alternative to intravenous immune globulin | Researchers | Clinical research |
Therapeutic Apheresis | Pavenski K | 2018 | Clinical Guide to Transfusion | View Therapeutic Apheresis | Health care providers | Benchmarking and standard setting |
Blood bag spiking procedure | Shimla S, Jenkins C, McTaggart K | 2018 | Blood.ca website | View Blood bag spiking procedure | Other | Other |
GPIb? is required for platelet-mediated hepatic thrombopoietin generation | Xu M, Li J, Neves MAD, Zhu G, Carrim N, Yu R, Gupta S, Marshall J, Rotstein O, Peng J, Hou M, Kunishima S, Ware J, Branch DR, Lazarus A, Ruggeri ZM, Freedman J, Ni H | 2018 | Blood | View GPIb? is required for platelet-mediated hepatic thrombopoietin generation | Researchers | Basic research |
Does treatment order matter? Investigating the ability of bacteriophage to augment antibiotic activity against Staphylococcus aureus biofilms | Kumaran D, Taha M, Yi Q, Ramirez-Arcos S, Diallo JS, Carli A, Abdelbary H | 2018 | Front Microbiol | View Does treatment order matter? Investigating the ability of bacteriophage to augment antibiotic activity against Staphylococcus aureus biofilms | Researchers | Basic research |
rIgG1 Fc hexamer inhibits antibody-mediated autoimmune disease via effects on complement and FcgammaRs | Spirig R, Campbell IK, Koernig S, Chen CG, Lewis BJB, Butcher R, Muir I, Taylor S, Chia J, Leong D, Simmonds J, Scotney P, Schmidt P, Fabri L, Hofmann A, Jordi M, Spycher MO, Cattepoel S, Brasseit J, Panousis C, Rowe T, Branch DR, Baz Morelli A, Kasermann F, Zuercher AW | 2018 | J Immunol | View rIgG1 Fc hexamer inhibits antibody-mediated autoimmune disease via effects on complement and FcgammaRs | Researchers | Basic research |
Unrelated donor choices for allogeneic hematopoietic cell transplantation in Canada: an evaluation of factors influencing donor selection | Greco-Stewart V, Kiernan J, Killeen D, Haun S, Mercer D, Young K, Liwski RS, Allan DS | 2018 | Transfusion | View Unrelated donor choices for allogeneic hematopoietic cell transplantation in Canada: an evaluation of factors influencing donor selection | Health care providers | Clinical research |
Immune Globulin Products | Harding R, Lazarus A | 2018 | Clinical Guide to Transfusion | View Immune Globulin Products | Health care providers | Other |
Improving quality of care for patients with iron deficiency anemia presenting to the emergency department | Khadadah F, Callum J, Shelton D, Lin Y | 2018 | Transfusion | View Improving quality of care for patients with iron deficiency anemia presenting to the emergency department | Health care providers | Clinical research |
Cellular immune responses to platelet factor 4 and heparin complexes in patients with heparin-induced thrombocytopenia | Nazy I, Clare R, Staibano P, Warkentin TE, Larché M, Moore JC, Smith JW, Whitlock RP, Kelton JG, Arnold DM | 2018 | J Thromb Haemost | View Cellular immune responses to platelet factor 4 and heparin complexes in patients with heparin-induced thrombocytopenia | Researchers | Clinical research |
Modulating Intracellular Ice Growth with Cell-Permeating Small-Molecule Ice Recrystallization Inhibitors | Poisson JS, Acker JP, Briard JG, Meyer JE, Ben RN | 2018 | Langmuir | View Modulating Intracellular Ice Growth with Cell-Permeating Small-Molecule Ice Recrystallization Inhibitors | Researchers | Basic research |
The Monocyte Monolayer Assay: Past, Present and Future | Tong TN, Cen S, Branch DR | 2018 | Transfus Med Rev | View The Monocyte Monolayer Assay: Past, Present and Future | Researchers | Basic research |
Development of a proof of principle for universal neutralization of antibiotics in cord blood by-products used for sterility testing | Kou Y, Halpenny M, Elmoazzen H, Ramirez-Arcos S | 2018 | Transfusion | View Development of a proof of principle for universal neutralization of antibiotics in cord blood by-products used for sterility testing | Researchers | New or improved product or process |
Targeting transfusion-related acute lung injury: the journey from basic science to novel therapies | Semple JW, McVey MJ, Kim M, Rebetz J, Kuebler WM, Kapur R | 2018 | Crit Care Med | View Targeting transfusion-related acute lung injury: the journey from basic science to novel therapies | Researchers | Basic research |